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Abstract	A literature review was conducted to determine what clinical interventions have been studied and
implemented to prevent and/or reduce postpartum hypertension readmissions. Appropriate verbal
and printed educational materials should be given to the patient prior to discharge with use of the
“teach back” method. Patients and health care providers within the multidisciplinary team should
be educated on the warning signs and symptoms of worsening hypertensive disease and when to
appropriately involve the obstetrician. The use of text messaging may be useful in preventing hospital
readmissions by increasing patient follow-up and compliance and appropriately managing patients in
the postpartum period. Treating postpartum patients with furosemide may decrease blood pressure
and prevent postpartum hypertension and the need for antihypertensive therapy. (J Patient Cent Res
Rev. 2016;3:150-152.)
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Clinical Question
What clinical interventions have been implemented
to prevent or reduce postpartum hypertension
readmissions?

that were searchable in PubMed or Google Scholar,
written in the English language, and that focused on
clinical interventions to reduce/prevent postpartum
hypertension readmissions.

Answer
Limited studies have reported on clinical interventions
focused on preventing and reducing postpartum
hypertension readmissions. To date, no reliable
evidence yet exists to appropriately guide management
for these patients in the postpartum period, though
emphasis has been placed on appropriate patient
education, targeting at-risk patients and establishing
proper follow-up after discharge.

Exclusion Criteria
Publications reporting readmissions for other causes,
such as infection, headache without hypertension,
venous thromboembolism or cardiac disease unrelated
to hypertension, were excluded, as were editorials
and perspectives. Publications providing antepartum
hypertensive guidelines also were excluded, as these
did not appropriately address the clinical question.

Date answer was determined: March 2016.
Level of evidence: B.
Inclusion Criteria
Publications from January 2006 to March 2016
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Summary of Problem
Hospital readmission rates are a critical component
in health care performance measures and costs, and
have been the focus of the Centers for Medicare and
Medicaid Services’ attention, thus prompting efforts
to improve health care quality and patient education.1
In 2009, 27% of obstetric readmissions were due to
hypertensive disease.2 Maternal blood pressure peaks
3–6 days after delivery, when patients have already
been discharged home.3 As a result, postpartum
hypertension readmissions make up a significant
portion of obstetrical readmissions and contribute to
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overall hospital readmission rates. Factors contributing
to postpartum hypertension readmissions rates may
include: provider and patient lack of knowledge
regarding the disease process and progression, lack
of standardized management and treatment plans,
and insufficient patient education. Task Force on
Hypertension in Pregnancy guidelines have been
established by the American College of Obstetricians
and Gynecologists for management of maternal
hypertension in labor and delivery, but these do not
address management during the postpartum period.1
Postpartum hypertension not only significantly impacts
health care costs but also contributes to maternal
morbidity including stroke and mortality.3
Summary of Evidence
Of the initial 58 studies identified by our search strategy,
only five satisfied the inclusion and exclusion criteria.
The first finding from our search was a presentation
within the American Hospital Association’s “Health
Care Leader Action Guide to Reduce Avoidable
Readmissions.”2 This summary report identified several
strategies to reduce avoidable readmissions throughout
patient care. During hospitalization, it is recommended
that health care providers: screen patients for risk
factors for readmission and tailor care appropriately,
establish effective communication with the patient and
family, use the “teach back” method for education and
comprehension (i.e. patients are asked to reiterate their
understanding of the information communicated), and
coordinate patient care across multidisciplinary teams.
Upon discharge, it is recommended that caregivers:
implement comprehensive discharge planning, use
the “teach back” method for discharge planning,
and schedule follow-up appointments as indicated.
Postdischarge, it is recommended that health care
providers: promote patient self-management of their
diagnosis, conduct home visits, and follow up with the
patient via the telephone.2
Al-Safi et al. studied demographics and clinical
factors that may play a role in delayed postpartum
preeclampsia and eclampsia, thereby contributing to
postpartum hypertension readmissions.4 In terms of
the demographics collected –– age, gravidity, body
mass index, ethnicity, history of hypertensive disease
and other comorbidities –– young age was the only
significant demographic variable for developing
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eclampsia. All patients studied presented with
prodromal symptoms, with headache being the most
common. The authors emphasized the need to educate
emergency department providers on prodromal
symptoms given that most of the patients were initially
evaluated in this setting, and patients on warning signs
and symptoms of their diagnosis prior to discharge
to potentially avoid complications and development
of postpartum preeclampsia or eclampsia. Patient
education should occur prior to hospital discharge
using both verbal and printed materials.4
With a design based on evidence that hypertensive
complications frequently occur within 7 days
postpartum, the third study evaluated the use of
provider-patient text messaging as an avenue for
increased outreach prior to follow-up appointments.5
The text messaging intervention sought “to provide
reassurance, answers to questions and problem-solving
solutions, and to identify women who needed escalated
care.” A member of the patient’s health care team sent
a standardized text message to patients within 3 to
4 days following hospital discharge. Response rate
was 34%, and 27% required a follow-up phone call
for additional information and triage. Participants
reported satisfaction with this method of enhanced
communication and follow-up; however, further
research needs to be performed to determine if this
method reduces readmission rates.5
A Cochrane review titled “Prevention and Treatment
of Postpartum Hypertension” sought to determine if
any evidence-based recommendations exist to guide
management (though not specifically to determine ways
to reduce readmissions, as was our goal) of postpartum
hypertensive patients.3 The review included nine trials,
all of which studied the effects of different medications
commonly used in pregnancy and in the postpartum
period, including furosemide, nifedipine, timolol,
hydralazine, methyldopa and labetalol. The review
concluded that “postnatal furosemide may decrease
the need for postnatal antihypertensive therapy in
the hospital, but more data are needed on substantive
outcomes before this practice can be recommended.”3
The authors suggested that the use of furosemide
may be beneficial in reducing blood pressure, thus
potentially reducing readmission rates and maternal
health complications.
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Understanding the clinical factors associated with
postpartum hypertension readmissions may assist
in identifying and targeting appropriate patient
populations. In a study conducted by Hirshberg et al.,
several labor, delivery and postpartum factors, such
as demographics, mode of delivery, length of labor,
severity of hypertensive disease, use of magnesium
sulfate, fluid balance, initiation of antihypertensive
medication and postpartum blood pressure prior to
discharge, were examined to determine their association
with hospital readmission.1 Interestingly, readmitted
patients were noted to have longer lengths of labor
and were less likely to be initiated on antihypertensive
therapy prior to discharge.
Conclusions
Provider and patient education, verbal and printed
resources, text messaging with prompt follow-up
postdischarge and the use of postnatal furosemide
appear to exhibit the potential to decrease the morbidity
and mortality associated with postpartum hypertensive
disease and hospital readmission.
Patient-Friendly Recap
• There are currently no evidence-based
management guidelines for treating postpartum
hypertension.
• The authors reviewed published reports
for evidence that may support any clinical
interventions to prevent hospital readmission
caused by postpartum hypertension.
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• They found that providing educational materials
to both caregivers and patients, administering
furosemide after the birth, and use of two-way
text messaging for follow-up management all
may serve to decrease related complications and
readmissions.
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